Page last updated: 2024-11-13
inotodiol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
inotodiol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 44422314 |
CHEMBL ID | 449088 |
SCHEMBL ID | 24065966 |
MeSH ID | M0506650 |
Synonyms (11)
Synonym |
---|
inotodiol |
CHEMBL449088 |
Q15634152 |
MS-27970 |
DTXSID10957379 |
(22r)-5alpha-lanosta-8,24-diene-3beta,22-diol |
HY-120149 |
CS-0077023 |
SCHEMBL24065966 |
E83702 |
AKOS040744638 |
Research Excerpts
Overview
Inotodiol is a lanostane triterpenoid isolated from Inonotus obliquus. It had been extensively reported to be an anti-inflammatory agent. Its effect on arthritis remains unknown.
Effects
Excerpt | Reference | Relevance |
---|---|---|
"Inotodiol has been proven to have antitumor, antiviral, anti-inflammatory, and antiallergic properties. " | ( Inotodiol suppresses allergic inflammation in allergic rhinitis mice. Choi, MR; Chung, EH; Chung, J; Kang, JY; Kim, YM; Park, JT; Park, SK, 2023) | 3.8 |
Actions
Excerpt | Reference | Relevance |
---|---|---|
"Inotodiol can inhibit proliferation and induce the apoptosis of A549 cells, and its molecular mechanism may be associated with the up-regulating expression of p53 and bax proteins and down-regulating expression of Bcl-2 protein, which arrested A549 cells in S phase." | ( Effects of inotodiol extracts from inonotus obliquus on proliferation cycle and apoptotic gene of human lung adenocarcinoma cell line A549. Sun, DZ; Wang, LB; Zhong, XH, 2011) | 2.2 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (15)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID284049 | Cell viability in Raji cells at 1000 mol ratio/TPA relative to control | 2007 | Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1 | Structure determination of inonotsuoxides A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of Inonotus obliquus. |
AID284048 | Inhibition of TPA-induced EBV-EA activation in Raji cells at 10 mol ratio/TPA relative to control | 2007 | Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1 | Structure determination of inonotsuoxides A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of Inonotus obliquus. |
AID711411 | Cytotoxicity against human COLO205 cells | 2012 | Journal of natural products, Nov-26, Volume: 75, Issue:11 | Lanostanoids from fungi: a group of potential anticancer compounds. |
AID711412 | Antitumor activity against mouse P388 cells allografted in CDF1 mouse assessed as increase in survival rate at 10 mg/kg | 2012 | Journal of natural products, Nov-26, Volume: 75, Issue:11 | Lanostanoids from fungi: a group of potential anticancer compounds. |
AID711414 | Antitumor activity against mouse P388 cells allografted in CDF1 mouse assessed as increase in survival rate at 3 mg/kg | 2012 | Journal of natural products, Nov-26, Volume: 75, Issue:11 | Lanostanoids from fungi: a group of potential anticancer compounds. |
AID711416 | Cytotoxicity against human HL60 cells | 2012 | Journal of natural products, Nov-26, Volume: 75, Issue:11 | Lanostanoids from fungi: a group of potential anticancer compounds. |
AID284045 | Suppression of DMBA/TPA-induced papilloma-formation in ICR mouse within 10 week | 2007 | Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1 | Structure determination of inonotsuoxides A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of Inonotus obliquus. |
AID284044 | Inhibition of TPA-induced EBV-EA activation in Raji cells at 500 mol ratio/TPA relative to control | 2007 | Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1 | Structure determination of inonotsuoxides A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of Inonotus obliquus. |
AID1063365 | Hepatoprotective activity against D-galactosamine-induced toxicity in rat WB-F344 cells assessed as cell survival at 10 uM preincubated for 1 hr followed by D-galactosamine challenge measured after 24 hrs by MTT assay relative to normal cell | 2014 | Journal of natural products, Jan-24, Volume: 77, Issue:1 | Chemical constituents from Inonotus obliquus and their biological activities. |
AID284047 | Inhibition of TPA-induced EBV-EA activation in Raji cells at 100 mol ratio/TPA relative to control | 2007 | Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1 | Structure determination of inonotsuoxides A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of Inonotus obliquus. |
AID284050 | Toxicity in ICR mouse with DMBA/TPA-induced papilloma | 2007 | Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1 | Structure determination of inonotsuoxides A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of Inonotus obliquus. |
AID284043 | Inhibition of TPA-induced EBV-EA activation in Raji cells at 1000 mol ratio/TPA relative to control | 2007 | Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1 | Structure determination of inonotsuoxides A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of Inonotus obliquus. |
AID711410 | Cytotoxicity against mouse L1210 cells | 2012 | Journal of natural products, Nov-26, Volume: 75, Issue:11 | Lanostanoids from fungi: a group of potential anticancer compounds. |
AID1063364 | Hepatoprotective activity in rat WB-F344 cells assessed as inhibition of D-galactosamine-induced toxicity at 10 uM preincubated for 1 hr followed by D-galactosamine challenge measured after 24 hrs by MTT assay relative to control | 2014 | Journal of natural products, Jan-24, Volume: 77, Issue:1 | Chemical constituents from Inonotus obliquus and their biological activities. |
AID711413 | Antiproliferative activity against mouse P388 cells | 2012 | Journal of natural products, Nov-26, Volume: 75, Issue:11 | Lanostanoids from fungi: a group of potential anticancer compounds. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (21)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (9.52) | 29.6817 |
2010's | 10 (47.62) | 24.3611 |
2020's | 9 (42.86) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 25.31
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (25.31) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (4.35%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 22 (95.65%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |